MINDACT: (EORTC) A Prospective, Randomised Study Comparing the 70-Gene Signature with the Common Clinical-Pathological Criteria in Selecting Patients for Adjuvant Chemotherapy in Node-Negative Breast Cancer (year 4 renewal)